This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2013-2016.
Location History:
- Uijeongbu-si, KR (2013)
- Gyeonggi-do, KR (2016)
Company Filing History:
Years Active: 2013-2016
Title: Innovations by Seonghwan Lee
Introduction
Seonghwan Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biosensors and diagnostics, particularly in relation to cancer and malaria detection. With a total of 2 patents, his work is paving the way for advancements in medical diagnostics.
Latest Patents
Seonghwan Lee's latest patents include a DNA aptamer specifically binding to EN2 (engrailed-2) and its application in diagnosing prostate cancer. This invention addresses the detection specificity problem associated with the prostate-specific antigen (PSA) test, enhancing the accuracy of early prostate cancer diagnosis. His second patent involves a DNA aptamer that specifically binds to pLDH (plasmodium lactate dehydrogenase), which is crucial for malaria diagnosis. This innovation offers superior specificity and stability compared to conventional antibodies, significantly improving diagnostic accuracy for malaria.
Career Highlights
Seonghwan Lee is affiliated with the Pohang University of Science and Technology Foundation, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on early disease detection and treatment.
Collaborations
Seonghwan Lee has collaborated with notable colleagues, including Changill Ban and Yoon-Keun Kim, contributing to the advancement of his research and innovations.
Conclusion
Seonghwan Lee's contributions to the field of biosensors and diagnostics exemplify the importance of innovation in medical technology. His patents not only enhance diagnostic accuracy but also hold promise for improving patient outcomes in cancer and malaria detection.